The Clap
CVS Health (NYSE: CVS) recorded an EPS of $2.09 and revenue of $81.16 billion, beating analysts’ expectations on both the top and bottom lines.
The Deets
Revenue saw a 10% increase YoY. This quarter’s earnings mark the 3rd consecutive quarter that the company beat earnings expectations.
After topping estimates, the company increased its full-year outlook, with an estimated EPS range of $8.55 to $8.65.
So What
The company’s shares jumped more than 2% following the news.
Related News
CVS acquired Signify for $8 billion in September, the first step in the expansion into the at-home healthcare sector.